Name and Address of Beneficial Owner(1)
Number of
Shares
Percentage of
Common
Stock
Outstanding
5% or Greater Stockholders:
Ecosystem Integrity Fund II, L.P.(2) 8,399,653 12.3%
Thurman J. (T.J.) Rodgers(3) 10,891,582 16.3%
Entities affiliated with Alyeska Investment Group, L.P. (4) 7,236,624 10.9%
Entities Affiliated with Kline Hill (5) 7,299,695 10.3%
Executive Officers and Incumbent Directors and Director Nominees:
Thurman J. Rodgers(3) 10,891,582 16.3%
William J. Anderson(6) 2,691,833 3.9%
Antonio R. Alvarez(7) 94,452 *
Daniel Foley — —
Devin Whatley(2) 8,487,777 12.4%
Tidjane Thiam(8) 265,193 *
Adam Gishen(9) 268,468 *
Ronald Pasek(10) 113,437 *
Chris Lundell(11) 248,619 *
Lothar Maier — —
J. Daniel McCranie(12) — *
All directors and executive officers as a group (11 persons) 23,061,361 32.3%
* Less than one percent.
(1) Unless otherwise indicated, the business address of each of the directors and executive officers of the Company is c/o Complete Solaria, Inc., 45700
Northport Loop East, Fremont, CA 94538.
(2) Includes (i) 5,832,054 shares held by Ecosystem Integrity Fund II, L.P., of which Mr. Devin Whatley is the managing member of the general partner,
(ii) 198,346 shares held by EIF CS SPV LLC, and (iii) 2,369,253 shares issuable pursuant to Complete Solaria warrants exercisable within 60 days of
April 30, 2025. The business address of each of Ecosystem Integrity Fund II, L.P., EIF CS SPV LLC and Mr. Whatley is 20 Richelle Court, Lafayette,
California 94549. In the case of Mr. Whatley, also includes 88,124 shares issuable pursuant to stock options exercisable within 60 days of April 30,
2025.
(3) Includes (i) 485,562 shares held by Rodgers Capital, LLC, (ii) 8,842 shares held by Thurman J. Rodgers, (iii) 7,701,602 shares held by the Rodgers
Massey Revocable Living Trust, (iv) 1,838,235 shares held by the Rodgers Massey Freedom and Free Markets Charitable Trust, (v) 724,416 shares
issuable pursuant to Complete Solaria warrants exercisable within 60 days of April 30, 2025, and (vi) 132,925 shares issuable pursuant to stock
options exercisable within 60 days of April 30, 2025. The business address of the foregoing holders is 45700 Northport Loop East, Fremont,
CA 94538. In addition to the foregoing and the number of shares reflected in the table above, (a) the Rodgers Massey Revocable Living Trust holds
$18,000,000 principal amount of the July 2024 Notes, which, subject to the terms and conditions of the July 2024 Notes, are convertible into
10,714,285 shares of Common Stock, (b) the Rodgers Massey Revocable Living Trust and the Mordgers Massey Freedom and Free Markets
Charitable Trust own in the aggregate $8,000,000 principal amount of the September 2024 Notes, which, subject to the terms and conditions of the
September 2024 Notes, are convertible into 3,742,690 shares of Common Stock, and (c) 13,888,889 shares of Common Stock are issuable (but not
yet issued) as Amendment Shares in respect of the First Safe and the Second Safe (all as defined below).
(4) Based solely on information obtained from a Schedule 13G filed by Alyeska Investment Group, L.P. on February14, 2025. Represents 219,080
shares of Common Stock held by Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh, as well as 7,017,544 shares of
Common Stock issuable under the September 2024 Notes. The September 2024 Notes are not currently convertible in accordance with their terms.
The principal business address is 77 West Wacker Drive, 7th Floor, Chicago, IL 60601.
(5) Based solely on information obtained from a Schedule 13G filed by KHP Fund GP LLC (“KHP Fund GP”) on February 5, 2025. Includes (i) an
aggregate of 2,383,534 shares of Common Stock held by Kline Hill Partners Fund LP (“KHP LP”), Kline Hill Partners IV SPV LLC (“KHP IV SPV”) and
Kline Hill Partners Opportunity IV SPV LLC (“KHP Opportunity IV SPV”), (ii) an aggregate of 4,745,675 shares of Common Stock issuable upon the
conversion of the outstanding convertible promissory notes held by KHP LP, KHP IV SPV and KHP Opportunity IV SPV and (iii) an aggregate of
170,486 shares of Common Stock issuable upon the exercise of warrants held by KHP LP, KHP IV SPV and KHP Opportunity IV SPV. KHP Fund GP
is the general partner of KHP LP and may be deemed to share voting, investment and dispositive power with respect to these securities. Kline Hill
Partners Fund IV LP (“KHP IV LP”) is the sole member of KHP IV SPV and may be deemed to share voting, investment and dispositive power with
respect to these securities. KHP Fund IV GP is the general partner of KHP IV LP and may be deemed to share voting, investment and dispositive
power with respect to these securities. KHP Opportunity IV LP is the sole member of KHP Opportunity IV SPV and may be deemed to share voting,
investment and dispositive power with respect to these securities. KHP Fund IV GP is the general partner of KHP Opportunity IV LP and may be
deemed to share voting, investment and dispositive power with respect to these securities. Michael Bego and Jared Barlow are the managing
members of KHP Fund GP and KPH Fund IV GP and may be deemed to share voting, investment and dispositive power with respect to these
securities. Other than those securities reported herein as being held directly by such securityholder, each of them disclaims any such beneficial
ownership of such securities, except to the extent of their respective pecuniary interest. The business address for Kline Hill is 325 Greenwich Ave.,
3rd Floor, Greenwich, CT 06830.
75
(6) Includes (i) 934,751 shares of Common Stock, (ii) 1,615,895 shares issuable pursuant to stock options exercisable within 60 days of April 30, 2025,
and (iii) 141,187 shares issuable pursuant to Complete Solaria warrants exercisable within 60 days of April 30, 2025.
(7) Includes 94,452 shares issuable pursuant to stock options exercisable within 60 days of April 30, 2025.
(8) Includes (i) 158,624 shares of Common Stock, (ii) 12,117 shares issuable pursuant to Complete Solaria warrants exercisable within 60 days of April
30, 2025, and (iii) 94,452 shares issuable pursuant to stock options exercisable within 60 days of March 31, 2025.
(9) Includes (i) 167,742 shares of Common Stock, (ii) 1,211 shares issuable pursuant to Complete Solaria warrants exercisable within 60 days of April
30, 2025, and (iii) 99,515 shares issuable pursuant to stock options exercisable within 60 days of April 30, 2025.
(10) Includes 113,437 shares issuable pursuant to stock options exercisable within 60 days of April 30, 2025.
(11) Includes 248,619 shares issuable pursuant to stock options exercisable within 60 days of April 30, 2025.